Favorable response of relapsed/refractory gray-zone lymphoma to brentuximab vedotin View Full Text


Ontology type: schema:ScholarlyArticle     

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-017-3179-3

DOI

http://dx.doi.org/10.1007/s00277-017-3179-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1093136421

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29198035


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Immunological", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brentuximab Vedotin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoconjugates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ki-1 Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma, B-Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron Emission Tomography Computed Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rituximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salvage Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Jamilla", 
        "id": "sg:person.014201605037.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014201605037.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sim", 
        "givenName": "Joycelyn", 
        "id": "sg:person.011416733702.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011416733702.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leung", 
        "givenName": "Anskar Y. H.", 
        "id": "sg:person.011121156664.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011121156664.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kwong", 
        "givenName": "Yok-Lam", 
        "id": "sg:person.01100514066.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100514066.14"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2017-12-02", 
    "datePublishedReg": "2017-12-02", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-017-3179-3", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "97"
      }
    ], 
    "keywords": [
      "gray zone lymphoma", 
      "brentuximab vedotin", 
      "favorable response", 
      "lymphoma", 
      "response"
    ], 
    "name": "Favorable response of relapsed/refractory gray-zone lymphoma to brentuximab vedotin", 
    "pagination": "551-554", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1093136421"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-017-3179-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29198035"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-017-3179-3", 
      "https://app.dimensions.ai/details/publication/pub.1093136421"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:36", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_733.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-017-3179-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-017-3179-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-017-3179-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-017-3179-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-017-3179-3'


 

This table displays all metadata directly associated to this object as RDF triples.

166 TRIPLES      19 PREDICATES      49 URIs      41 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-017-3179-3 schema:about N06fefa07967643079bf5c8c933994f86
2 N09eb8e55a8c2462791d5e632e118f11c
3 N19978b62e44049e18d58076f16790ed9
4 N37c2f674048346c48bd76e4d31b7ee00
5 N558052c2886c4913bc745a17252b025c
6 N5d9289d2c3074207ad6e39ae483cb78e
7 N60db28fad4a84898a00942fd5c057d08
8 N6c35e033d66d4c2a8baebf2965eb4275
9 N876d740475a249ebb7a2ed623c88e7c0
10 N8b6c1d1684454220b4d2bcc35bb8c66f
11 N986c1c3086824c19a46a0869032fd9a2
12 N9905171f1aae4880afe5dcc4a7b0e732
13 N9ddd440f0bfd4ab2ac2698c398785358
14 Na145627987424a2b85fbed326c9f2d2c
15 Nb3d865fb959243e0ae5eb9cd396abe7c
16 Nb8d1d186530b431cbd6a6beada73ab52
17 Nb9b76435a0d64aae8e4caed1ae8675b1
18 Ncf44f198201b4f04ab14875d76ca09ff
19 Nd4feb31712554788ae254f50eacd67a5
20 Nee83fd54e8154fa5873a55bcedd9ce2f
21 anzsrc-for:11
22 anzsrc-for:1102
23 schema:author N2a65a805b6354f709053fc7e2f78d8e7
24 schema:datePublished 2017-12-02
25 schema:datePublishedReg 2017-12-02
26 schema:genre article
27 schema:isAccessibleForFree false
28 schema:isPartOf N7ecb00d32a284820a7e405d34fb77a32
29 Nf4cc1975677f4507aeba1996a4be48e4
30 sg:journal.1358129
31 schema:keywords brentuximab vedotin
32 favorable response
33 gray zone lymphoma
34 lymphoma
35 response
36 schema:name Favorable response of relapsed/refractory gray-zone lymphoma to brentuximab vedotin
37 schema:pagination 551-554
38 schema:productId N1e3f936f0d7b490bae56f2789c6d9a1a
39 N33c3429c5c114d1db0bd653d8289fb8c
40 N5f3f6c4b247244728dd808e75fd9ac02
41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1093136421
42 https://doi.org/10.1007/s00277-017-3179-3
43 schema:sdDatePublished 2022-12-01T06:36
44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
45 schema:sdPublisher N75ced6e3c7cf4f018ca684c94fbcb4ed
46 schema:url https://doi.org/10.1007/s00277-017-3179-3
47 sgo:license sg:explorer/license/
48 sgo:sdDataset articles
49 rdf:type schema:ScholarlyArticle
50 N06fefa07967643079bf5c8c933994f86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
51 schema:name Antineoplastic Agents, Immunological
52 rdf:type schema:DefinedTerm
53 N09eb8e55a8c2462791d5e632e118f11c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
54 schema:name Hematopoietic Stem Cell Transplantation
55 rdf:type schema:DefinedTerm
56 N12986ef0d0904f3abc7d9ed5d9c310d4 rdf:first sg:person.011416733702.66
57 rdf:rest N2b9bff6fda8e421ba72da5914b87270c
58 N19978b62e44049e18d58076f16790ed9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Lymphoma, B-Cell
60 rdf:type schema:DefinedTerm
61 N1e3f936f0d7b490bae56f2789c6d9a1a schema:name pubmed_id
62 schema:value 29198035
63 rdf:type schema:PropertyValue
64 N2a65a805b6354f709053fc7e2f78d8e7 rdf:first sg:person.014201605037.80
65 rdf:rest N12986ef0d0904f3abc7d9ed5d9c310d4
66 N2b9bff6fda8e421ba72da5914b87270c rdf:first sg:person.011121156664.42
67 rdf:rest N54f342db5c584ce4b11ab9d6684dd273
68 N33c3429c5c114d1db0bd653d8289fb8c schema:name doi
69 schema:value 10.1007/s00277-017-3179-3
70 rdf:type schema:PropertyValue
71 N37c2f674048346c48bd76e4d31b7ee00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Middle Aged
73 rdf:type schema:DefinedTerm
74 N54f342db5c584ce4b11ab9d6684dd273 rdf:first sg:person.01100514066.14
75 rdf:rest rdf:nil
76 N558052c2886c4913bc745a17252b025c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Antineoplastic Combined Chemotherapy Protocols
78 rdf:type schema:DefinedTerm
79 N5d9289d2c3074207ad6e39ae483cb78e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Remission Induction
81 rdf:type schema:DefinedTerm
82 N5f3f6c4b247244728dd808e75fd9ac02 schema:name dimensions_id
83 schema:value pub.1093136421
84 rdf:type schema:PropertyValue
85 N60db28fad4a84898a00942fd5c057d08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Drug Resistance, Neoplasm
87 rdf:type schema:DefinedTerm
88 N6c35e033d66d4c2a8baebf2965eb4275 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Immunoconjugates
90 rdf:type schema:DefinedTerm
91 N75ced6e3c7cf4f018ca684c94fbcb4ed schema:name Springer Nature - SN SciGraph project
92 rdf:type schema:Organization
93 N7ecb00d32a284820a7e405d34fb77a32 schema:volumeNumber 97
94 rdf:type schema:PublicationVolume
95 N876d740475a249ebb7a2ed623c88e7c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Adult
97 rdf:type schema:DefinedTerm
98 N8b6c1d1684454220b4d2bcc35bb8c66f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Male
100 rdf:type schema:DefinedTerm
101 N986c1c3086824c19a46a0869032fd9a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Young Adult
103 rdf:type schema:DefinedTerm
104 N9905171f1aae4880afe5dcc4a7b0e732 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Positron Emission Tomography Computed Tomography
106 rdf:type schema:DefinedTerm
107 N9ddd440f0bfd4ab2ac2698c398785358 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Ki-1 Antigen
109 rdf:type schema:DefinedTerm
110 Na145627987424a2b85fbed326c9f2d2c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Combined Modality Therapy
112 rdf:type schema:DefinedTerm
113 Nb3d865fb959243e0ae5eb9cd396abe7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Brentuximab Vedotin
115 rdf:type schema:DefinedTerm
116 Nb8d1d186530b431cbd6a6beada73ab52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Rituximab
118 rdf:type schema:DefinedTerm
119 Nb9b76435a0d64aae8e4caed1ae8675b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Antigens, Neoplasm
121 rdf:type schema:DefinedTerm
122 Ncf44f198201b4f04ab14875d76ca09ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Humans
124 rdf:type schema:DefinedTerm
125 Nd4feb31712554788ae254f50eacd67a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Salvage Therapy
127 rdf:type schema:DefinedTerm
128 Nee83fd54e8154fa5873a55bcedd9ce2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Female
130 rdf:type schema:DefinedTerm
131 Nf4cc1975677f4507aeba1996a4be48e4 schema:issueNumber 3
132 rdf:type schema:PublicationIssue
133 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
134 schema:name Medical and Health Sciences
135 rdf:type schema:DefinedTerm
136 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
137 schema:name Cardiorespiratory Medicine and Haematology
138 rdf:type schema:DefinedTerm
139 sg:journal.1358129 schema:issn 0939-5555
140 1432-0584
141 schema:name Annals of Hematology
142 schema:publisher Springer Nature
143 rdf:type schema:Periodical
144 sg:person.01100514066.14 schema:affiliation grid-institutes:grid.415550.0
145 schema:familyName Kwong
146 schema:givenName Yok-Lam
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100514066.14
148 rdf:type schema:Person
149 sg:person.011121156664.42 schema:affiliation grid-institutes:grid.415550.0
150 schema:familyName Leung
151 schema:givenName Anskar Y. H.
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011121156664.42
153 rdf:type schema:Person
154 sg:person.011416733702.66 schema:affiliation grid-institutes:grid.415550.0
155 schema:familyName Sim
156 schema:givenName Joycelyn
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011416733702.66
158 rdf:type schema:Person
159 sg:person.014201605037.80 schema:affiliation grid-institutes:grid.415550.0
160 schema:familyName Li
161 schema:givenName Jamilla
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014201605037.80
163 rdf:type schema:Person
164 grid-institutes:grid.415550.0 schema:alternateName Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China
165 schema:name Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China
166 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...